Dunaieva, I. 2025. Liraglutide as a means of modifying cardiometabolic risk in patients with arterial hypertension and concomitant obesity. Inter Collegas. 12, 2 (Apr. 2025). DOI:https://doi.org/10.35339/ic.2025.12.2.dun.